Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
View ORCID ProfileWatsamon Jantarabenjakul, Napaporn Chantasrisawad, Thanyawee Puthanakit, Supaporn Wacharapluesadee, Nattiya Hirankarn, Vichaya Ruenjaiman, Leilani Paitoonpong, Gompol Suwanpimolkul, Pattama Torvorapanit, Rakchanok Pradit, Jiratchaya Sophonphan, Opass Putcharoen
doi: https://doi.org/10.1101/2021.08.27.21262721
Watsamon Jantarabenjakul
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
2Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MD PhDNapaporn Chantasrisawad
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
2Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MDThanyawee Puthanakit
2Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MDSupaporn Wacharapluesadee
4King Chulalongkorn Memorial Hospital, Bangkok, Thailand
PhDNattiya Hirankarn
5Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MD PhDVichaya Ruenjaiman
5Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
PhDLeilani Paitoonpong
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
6Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MDGompol Suwanpimolkul
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
6Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MDPattama Torvorapanit
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
MDRakchanok Pradit
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
MSNJiratchaya Sophonphan
7The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Opass Putcharoen
1Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
6Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
MDData Availability
The data that support the findings of this study are available on request from the corresponding author, [OP]. The data are not publicly available due to their containing information that could compromise the privacy of research participants.
Posted August 30, 2021.
Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
Watsamon Jantarabenjakul, Napaporn Chantasrisawad, Thanyawee Puthanakit, Supaporn Wacharapluesadee, Nattiya Hirankarn, Vichaya Ruenjaiman, Leilani Paitoonpong, Gompol Suwanpimolkul, Pattama Torvorapanit, Rakchanok Pradit, Jiratchaya Sophonphan, Opass Putcharoen
medRxiv 2021.08.27.21262721; doi: https://doi.org/10.1101/2021.08.27.21262721
Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
Watsamon Jantarabenjakul, Napaporn Chantasrisawad, Thanyawee Puthanakit, Supaporn Wacharapluesadee, Nattiya Hirankarn, Vichaya Ruenjaiman, Leilani Paitoonpong, Gompol Suwanpimolkul, Pattama Torvorapanit, Rakchanok Pradit, Jiratchaya Sophonphan, Opass Putcharoen
medRxiv 2021.08.27.21262721; doi: https://doi.org/10.1101/2021.08.27.21262721
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2630)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12183)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4071)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2628)
- Health Policy (998)
- Hematology (362)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3840)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (449)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)